Appraisal of GABA and PABA as linker: Design and synthesis of novel benzamide based histone deacetylase inhibitorsRAJAK, Harish; KUMAR, Pramod; PARMAR, Poonam et al.European journal of medicinal chemistry. 2012, Vol 53, pp 390-397, issn 0223-5234, 8 p.Article

Discovery and development of SAHA as an anticancer agentMARKS, P. A.Oncogene (Basingstoke). 2007, Vol 26, Num 9, pp 1351-1356, issn 0950-9232, 6 p.Article

A novel series of L-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: Design, synthesis and molecular modeling studyDAWEI HUANG; XIAOHUI LI; YINGDONG WEI et al.European journal of medicinal chemistry. 2012, Vol 52, pp 111-122, issn 0223-5234, 12 p.Article

Histone Deacetylase Inhibitors Promote the Tumoricidal Effect of HAMLETBREST, Patrick; GUSTAFSSON, Mattias; MOSSBERG, Ann-Kristin et al.Cancer research (Baltimore). 2007, Vol 67, Num 23, pp 11327-11334, issn 0008-5472, 8 p.Article

A Novel Agent with Histone Deacetylase Inhibitory Activity Attenuates Neointimal HyperplasiaRAHMATZADEH, M; LIU, H. B; KRISHNA, S. M et al.Cardiovascular drugs and therapy. 2014, Vol 28, Num 5, pp 395-406, issn 0920-3206, 12 p.Article

Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?NOLAN, L; JOHNSON, P. W. M; GANESAN, A et al.British journal of cancer. 2008, Vol 99, Num 5, pp 689-694, issn 0007-0920, 6 p.Article

A simple and sensitive high-performance liquid chromatographic method for quantification of PXD101, a histone deacetylase inhibitor in human plasmaNINGNING ZHANG; BOON CHER GOH; YOK MOI KHOO et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 231-235, issn 0163-4356, 5 p.Article

FK228 (depsipeptide) : a HDAC inhibitor with pleiotropic antitumor activitiesKONSTANTINOPOULOS, Panagiotis A; VANDOROS, Gerasimos P; PAPAVASSILIOU, Athanasios G et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 5, pp 711-715, issn 0344-5704, 5 p.Article

Histone deacetylase inhibitors induce antigen specific anergy in lymphocytes : A comparative studyEDENS, R. Erik; DAGTAS, Selma; GILBERT, Kathleen M et al.International immunopharmacology. 2006, Vol 6, Num 11, pp 1673-1681, issn 1567-5769, 9 p.Article

HDAC inhibitors attenuate the development of hypersensitivity in models of neuropathic painDENK, Franziska; WENLONG HUANG; MCMAHON, Stephen B et al.Pain (Amsterdam). 2013, Vol 154, Num 9, pp 1668-1679, issn 0304-3959, 12 p.Article

Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A, a histone deacetylase inhibitorJIN HO KIM; JIN HEE SHIN; IL HAN KIM et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 4, pp 1174-1180, issn 0360-3016, 7 p.Article

Radiosensitization by the Histone Deacetylase Inhibitor PCI-24781BANUELOS, Carmen A; BANATH, Judit P; MACPHAIL, Susan H et al.Clinical cancer research. 2007, Vol 13, Num 22, pp 6816-6826, issn 1078-0432, 11 p., 1Article

Targeting epigenetic abnormalities with histone deacetylase inhibitorsCONLEY, Barbara A; WRIGHT, John J; KUMMAR, Shivaani et al.Cancer. 2006, Vol 107, Num 4, pp 832-840, issn 0008-543X, 9 p.Article

Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoterYOKOTA, Tomoya; MATSUZAKI, Youichirou; MIYAZAWA, Kazuhiro et al.Oncogene (Basingstoke). 2004, Vol 23, Num 31, pp 5340-5349, issn 0950-9232, 10 p.Article

Histone deacetylase inhibitors specifically kill nonproliferating tumour cellsBURGESS, Andrew; RUEFLI, Astrid; BEAMISH, Heather et al.Oncogene (Basingstoke). 2004, Vol 23, Num 40, pp 6693-6701, issn 0950-9232, 9 p.Article

Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of angiogenesis factorsSASAKAWA, Yuka; NAOE, Yoshinori; NOTO, Takahisa et al.Biochemical pharmacology. 2003, Vol 66, Num 6, pp 897-906, issn 0006-2952, 10 p.Article

Histone Deacetylase Inhibitor Enhances Recovery after AKICIANCIOLO COSENTINO, Chiara; SKRYPNYK, Nataliya I; DAVIDSON, Alan J et al.Journal of the American Society of Nephrology. 2013, Vol 24, Num 6, pp 943-953, issn 1046-6673, 11 p.Article

Romidepsin for Cutaneous T-cell LymphomaMILES PRINCE, H; DICKINSON, Michael.Clinical cancer research (Print). 2012, Vol 18, Num 13, pp 3509-3515, issn 1078-0432, 7 p.Article

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repairGROSELJ, B; SHARMA, N. L; HAMDY, F. C et al.British journal of cancer. 2013, Vol 108, Num 4, pp 748-754, issn 0007-0920, 7 p.Article

Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: defining molecular mechanisms of resistanceSHAO, Wenlin; GROWNEY, Joseph D; YUN FENG et al.International journal of cancer (Print). 2010, Vol 127, Num 9, pp 2199-2208, issn 0020-7136, 10 p.Article

Antitumor effects of a novel sulfur-containing hydroxamate histone deacetylase inhibitor H40JUAN LONG; JINYAN ZHAO; ZHENG YAN et al.International journal of cancer (Print). 2009, Vol 124, Num 5, pp 1235-1244, issn 0020-7136, 10 p.Article

Epigenetics, DNA Methylation, and Chromatin Modifying DrugsSZYF, Moshe.Annual review of pharmacology and toxicology (Print). 2009, Vol 49, pp 243-263, issn 0362-1642, 21 p.Article

Histone deacetylase inhibitors : Apoptotic effects and clinical implications (Review)EMANUELE, Sonia; LAURICELLA, Marianna; TESORIERE, Giovanni et al.International journal of oncology. 2008, Vol 33, Num 4, pp 637-646, issn 1019-6439, 10 p.Article

In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitorsKONSOULA, Roula; JUNG, Mira.International journal of pharmaceutics. 2008, Vol 361, Num 1-2, pp 19-25, issn 0378-5173, 7 p.Article

Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinasePARK, Jung-Hyun; JONG, Hyun-Soon; SANG GYUN KIM et al.Journal of molecular medicine (Berlin. Print). 2008, Vol 86, Num 1, pp 117-128, issn 0946-2716, 12 p.Article